american diabetes association history of pancreatitis glp-1 receptor agonist GLP-1 Agonists and Pancreatitis Risk: Reassessing an Old Concern with New Evidence Frontiers | Association between different

Relevant for clinical practice, our findings show that treatment with semaglutide lowered the risk of MACE compared to sitagliptin, while tirzepatide showed at least comparable benefit to dulaglutide, an older GLP-1 receptor agonist with established cardiovascular efficacy

The combination can be beneficial because Ozempic and insulin function in various capacities to regulate blood sugar

The answer is yes, as they work through different pathways and complement each other well

[DOI] [PubMed] [Google Scholar] 171

You will need to draw the dose into a syringe yourself or use a reusable pen device

doi: 10.1016/j.cbi.2018.01.004